CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer

Liu, H; Zenati, MS; Rieser, CJ; Al-Abbas, A; Lee, KK; Singhi, AD; Bahary, N; Hogg, ME; Zeh, HJ; Zureikat, AH

Zureikat, AH (corresponding author), Univ Pittsburgh, Dept Surg, Div Gastrointestinal Surg Oncol, Med Ctr, Pittsburgh, PA 15260 USA.

ANNALS OF SURGICAL ONCOLOGY, 2020; 27 (10): 3950

Abstract

Background Neoadjuvant therapy (NAT) is increasingly utilized for pancreatic cancer, however the added benefit of adjuvant therapy (AT) in this settin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索